This trial is testing a new drug for people with lung cancer who have already tried other treatments. The goal is to see if it is safe and if it has any effect on the cancer.
2 Primary · 0 Secondary · Reporting Duration: 1 year
15 Total Participants · 1 Treatment Group
Primary Treatment: RO5126766 · No Placebo Group · Phase 1
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: